Emyria Limited [ASX:EMD] share price and news 2022

Company Description

Emyria Limited (EMD, formerly Emerald Clinics Limited) operates a Real-World Evidence using its network of specialist medical clinics and purpose-built, remote patient monitoring software and technology to gather high quality clinical data from informed and consenting patients. EMD’s model provides a clinical services and healthcare technology that focused on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines.

Emyria Limited belongs to Health Care sector and under industry of Health Care Facilities. You can get more information about this company via their website: http://www.emyria.com.

This a small cap company with market cap of 22 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 8.74 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how emd dividend grows in the recent years.

No data